TOSOH AIA- 1800 (96)

Specialty: General Immunology


Welcome to the PulseAid listing for the TOSOH AIA- 1800 medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Alpha-fetoprotein – tumor marker (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Beta-2 microglobulin (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
C-peptide (X040006 | X040006) MODERATE
Effective Date: 2004-04-29
CA 19-9 (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Cancer antigen 125 (CA 125) (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Cancer antigen 27.29 (CA 27.29) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Carcinoembryonic antigen (CEA) (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Cortisol (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Creatine kinase MB fraction (CKMB) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Estradiol (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Ferritin (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Folate, red blood cell (RBC folate) (K091332 | K091332) HIGH
Effective Date: 2009-10-08
Follicle stimulating hormone (FSH) (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
hCG, beta, serum, quantitative (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
hCG, Intact, serum, quantitative (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Human growth hormone (GH) (X040007 | X040007) MODERATE
Effective Date: 2004-04-29
Immunoglobulins IgE (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Insulin (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Luteinizing hormone (LH) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Myoglobin (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Progesterone (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Prolactin (K971103 | K971103) MODERATE
Effective Date: 2004-04-05
Prostatic acid phosphatase (PAP) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
T uptake (TU) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Testosterone (K023091 | K023091) MODERATE
Effective Date: 2004-06-28
Thyroid stimulating hormone (TSH) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18
Thyroxine (T4) (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Thyroxine uptake (T4U) (TU) (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Thyroxine, free (FT4) (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Triiodothyronine (T3) (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Triiodothyronine, free (FT3) (K971103 | K971103) MODERATE
Effective Date: 2005-02-17
Troponin-I (cardiac) (K971103 | K971103) MODERATE
Effective Date: 2003-12-18

Other General Immunology Devices:

Medical DeviceComplexity
Sanofi/Kallestad Total IgE MicroplateView Complexity
Abbott Architect c8000 SystemView Complexity
elias usa Synelisa Ro-Abs/La-AbsView Complexity
DiaSorin LIAISON AnalyzerView Complexity
ROCHE DIAGNOSTICS COBAS FARAView Complexity
GenBio Cytomegalovirus IgG IFA TestView Complexity
Abbott Rubazyme-MView Complexity
Roche Diagnostics Cobas MiraView Complexity
Pharmacia Phadezym IgE PRISTView Complexity
Roche Diagnostics Cobas Integra 400 PlusView Complexity